Dezhan Healthcare Co., Ltd. Class A

As of June 30, 2026, Dezhan Healthcare Co., Ltd. Class A carries a market capitalization of 6.35B, placing it among publicly traded companies globally. Its enterprise value stands at 5.06B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Dezhan Healthcare Co., Ltd. Class A has 2.10B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Dezhan Healthcare Co., Ltd. Class A maintains a current ratio of 15.90, meaning it holds 15.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Dezhan Healthcare Co., Ltd. Class A recorded an income tax benefit of -2.76M rather than an expense, typically from losses, carryforwards, or the release of a tax provision.

As of the close on October 23, 2026, Dezhan Healthcare Co., Ltd. Class A's stock has declined approximately 28.71% over the past 52 weeks. The 50-day moving average sits at 3.33, while the 200-day moving average is 3.50.

As of June 30, 2026, Dezhan Healthcare Co., Ltd. Class A holds 1.35B in cash and equivalents against 131.32M in total debt, resulting in a net debt position of -1.23B. Total book value stands at 4.58B, with working capital of 1.99B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Dezhan Healthcare Co., Ltd. Class A's most recent stock split took place on May 24, 2017 with a 2:3 split ratio.